Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
AMARIN TO REPORT THIRD QUARTER 2019 RESULTS AND HOST CONFERENCE CALL ON NOVEMBER 5, 2019
Source: https://investor.amarincorp.com/news-releases/news-release-details/amarin-report-third-quarter-2019-results-and-host-conference
Edit: NLA Position Paper of use of Icosapent Ethyl in High and Very-High-Risk patients @nationallipid #NLAFallCLU @NYUCVDPrevent pic.twitter.com/IYVVD8mN5D
I don't know the contents of the NLA position statement on the Use of Icosapent Ethyl on High and Very-High-Risk Patients, but in addition to Terry Jacobson (REDUCE-IT) being present, a recent paper by one of the other speakers is very promising,